Skip to main content

Table 3 Univariate analysis of factors affecting symptom control rate in 95 cases

From: Palliative radiotherapy in patients with a symptomatic pelvic mass of metastatic colorectal cancer

Characteristic One-year symptom control rate (%) p-value
Age   
< 60 years 22.6 0.5121
≥ 60 years 46.8  
Gender   
Male 45.1 0.1210
Female 29.2  
ECOG* performance status   
0-2 36.2 0.8387
3-4 27.0  
Primary site   
Colon cancer 38.8 0.9967
Rectal cancer 37.8  
Symptom   
Pain 32.1 0.1029
Bleeding 69.9  
Obstruction 37.5  
Biologically equivalent dose   
< 40 Gy10 28.5 0.0089
≥ 40 Gy10 40.5  
Re-irradiation   
Yes 41.0 0.3750
No 36.5  
Concurrent chemotherapy   
Yes 61.3 0.0644
No 33.2  
Adjuvant chemotherapy   
Yes 32.2 0.1986
No 46.8  
  1. * ECOG: Eastern Cooperative Oncology Group